RADX Annual ROE
-129.75%
-66.37%-104.72%
01 June 2024
Summary:
As of January 30, 2025, RADX annual return on equity is -129.75%, with the most recent change of -66.37% (-104.72%) on June 1, 2024. During the last 3 years, it has fallen by -78.96% (-155.46%). RADX annual ROE is now -155.46% below its all-time high of -50.79%, reached on June 1, 2022.RADX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RADX ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -104.7% | - |
| 3 y3 years | -155.5% | - |
| 5 y5 years | -155.5% | - |
RADX ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -155.5% | at low | ||
| 5 y | 5-year | -155.5% | at low | ||
| alltime | all time | -155.5% | at low |
Radiopharm Theranostics Limited ROE History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | -129.75%(+104.7%) | - |
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | -63.38%(+24.8%) | - |
| June 2022 | -50.79% | - |
FAQ
- What is Radiopharm Theranostics Limited annual return on equity?
- What is the all time high annual ROE for Radiopharm Theranostics Limited?
- What is Radiopharm Theranostics Limited annual ROE year-on-year change?
What is Radiopharm Theranostics Limited annual return on equity?
The current annual ROE of RADX is -129.75%
What is the all time high annual ROE for Radiopharm Theranostics Limited?
Radiopharm Theranostics Limited all-time high annual return on equity is -50.79%
What is Radiopharm Theranostics Limited annual ROE year-on-year change?
Over the past year, RADX annual return on equity has changed by -66.37% (-104.72%)